Fidelity Investments
VOR icon

Fidelity Investments’s Vor Biopharma VOR Stock Holding History

Fidelity Investments’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.8M Buy
4,932,149
+3,392,479
+220% +$51.3M ﹤0.01% 1262
2026
Q1 		$27.5M Sell
1,539,670
-986,500
-39% -$13.9M ﹤0.01% 1659
2025
Q4 		$33M Buy
2,526,170
+2,289,662
+968% +$42.6M ﹤0.01% 1593
2025
Q3 		$11.5M Buy
236,508
+131,874
+126% +$5.3M ﹤0.01% 1947
2025
Q2 		$3.39M Sell
104,634
-216,491
-67% -$1.91M ﹤0.01% 2302
2025
Q1 		$4.61M Buy
321,125
+143
+0% +$3.43K ﹤0.01% 2179
2024
Q4 		$7.13M Sell
320,982
-32,574
-9% -$540K ﹤0.01% 2043
2024
Q3 		$4.95M Sell
353,556
-234
-0.1% -$4.27K ﹤0.01% 2130
2024
Q2 		$7.08M Sell
353,790
-26,632
-7% -$861K ﹤0.01% 1973
2024
Q1 		$18M Sell
380,422
-525
-0.1% -$23.1K ﹤0.01% 1696
2023
Q4 		$17.1M Sell
380,947
-1,612
-0.4% -$66.5K ﹤0.01% 1679
2023
Q3 		$16.2M Sell
382,559
-1,850
-0.5% -$100K ﹤0.01% 1664
2023
Q2 		$23.8M Sell
384,409
-6,243
-2% -$570K ﹤0.01% 1576
2023
Q1 		$42M Sell
390,652
-7,874
-2% -$873K ﹤0.01% 1325
2022
Q4 		$53M Buy
398,526
+239,464
+151% +$23.7M 0.01% 1229
2022
Q3 		$12.7M Sell
159,062
-221
-0.1% -$21.7K ﹤0.01% 1802
2022
Q2 		$15.8M Buy
159,283
+5
+0% +$512 ﹤0.01% 1751
2022
Q1 		$19.2M Buy
159,278
+205
+0.1% +$34.9K ﹤0.01% 1799
2021
Q4 		$37M Sell
159,073
-1,197
-0.7% -$345K ﹤0.01% 1551
2021
Q3 		$50.3M Sell
160,270
-17,790
-10% -$5.29M ﹤0.01% 1408
2021
Q2 		$63.9M Sell
178,060
-5,792
-3% -$2.86M 0.01% 1325
2021
Q1 		$147M Buy
+183,852
New +$156M 0.01% 920

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Fidelity Investments's VOR Position: Q2 2026 in Review

Fidelity Investments increased its Vor Biopharma (VOR) stake by 220% in Q2 2026, buying an estimated $51.3M and bringing the position to 4,932,149 shares worth $90.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

Fidelity Investments first reported a position in VOR in Q1 2021 and has held it in 22 quarters since. The position peaked at $147M in Q1 2021. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Fidelity Investments held 4,932,149 shares of Vor Biopharma worth $90.8M as of Q2 2026.
  • Fidelity Investments bought 3,392,479 Vor Biopharma shares in Q2 2026, an estimated $51.3M.
  • Vor Biopharma made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1262 holding.
  • Fidelity Investments first reported a position in Vor Biopharma in Q1 2021 and has held it in 22 quarters since.
  • Fidelity Investments's Vor Biopharma position peaked at $147M in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.